Cerecor is building a global biopharmaceutical enterprise with a near-term pipeline of six clinical programs. All of our pipeline products have unique and novel mechanisms of action with the potential to be first-in-class compounds.
Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
Cerecor's pipeline of programs addresses unmet needs within Rare Pediatric and Orphan diseases.
Our goal is to make life-changing medicines available to under-served patient populations.
Members of our management team have extensive pharmaceutical product development and commercialization experience. Many members of our leadership team played key roles in the development and commercialization of numerous blockbuster products.
Collectively, our officers and directors have contributed to the submission of numerous Investigational New Drug Applications and New Drug Applications to the U.S. Food and Drug Administration (FDA) with subsequent approvals for Marketing Authorization.